| Title: | Hinge Binder Scaffold Hopping Identifies Potent Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CAMKK2) Inhibitor Chemotypes |
| Authors: | Eduful, BJ O’Byrne, SN Temme, L Asquith, CRM Liang, Y Picado, A Pilotte, JR Hossain, MA Wells, CI Zuercher, WJ Catta-Preta, CMC Ramos, PZ Santiago, AD Counago, RM Langendorf, CG Nay, K Oakhill, JS Pulliam, TL Lin, C Awad, D Willson, TM Frigo, DE Scott, JW Drewry, DH |
| Issue Year: | 2021 |
| Publisher | AMER CHEMICAL SOC |
| Series | JOURNAL OF MEDICINAL CHEMISTRY: |
| Abstract | CAMKK2 is a serine/threonine kinase and an activator of AMPK whose dysregulation is linked with multiple diseases. Unfortunately, STO-609, the tool inhibitor commonly used to probe CAMKK2 signaling, has limitations. To identify promising scaffolds as starting points for the development of high-quality CAMKK2 chemical probes, we utilized a hinge-binding scaffold hopping strategy to design new CAMKK2 inhibitors. Starting from the potent but promiscuous disubstituted 7-azaindole GSK650934, a total of 32 compounds, composed of single-ring, 5,6-, and 6,6-fused heteroaromatic cores, were synthesized. The compound set was specifically designed to probe interactions with the kinase hinge-binding residues. Compared to GSK650394 and STO-609, 13 compounds displayed similar or better CAMKK2 inhibitory potency in vitro, while compounds 13g and 45 had improved selectivity for CAMKK2 across the kinome. Our systematic survey of hinge-binding chemotypes identified several potent and selective inhibitors of CAMKK2 to serve as starting points for medicinal chemistry programs. |
| URI: | https://publications.svi.edu.au/publications/8396 |
| Other Identifiers | 10.1021/acs.jmedchem.0c02274 |
| Publication type | Article |